semaglutide for kidney disease The FDA just approved Ozempic Semaglutide just got FDA-approved for

These findings collectively underscore the promising strategy of pharmacologically targeting metabolic reprogramming in obese triplenegative breast cancer (TNBC) to overcome therapeutic resistance and curb tumor growth

Additionally, 36.8% of the semaglutide group had improvements in liver fibrosis, compared with 22.4% in the placebo group

Go beyond providing advice on increasing vitamin C or decreasing sugar and provide the tools to really help your patients succeed

Vojtek AB, Taylor J, DeRuiter SL, Yu JY, Figueroa C, Kwok RP, et al

A: Discuss alternative weight loss medications with your doctor

Action Step: Carry a reusable water bottle and aim for at least 64 to 80 ounces of water daily